The Biden Administration will make over 170 million doses of the bivalent COVID-19 vaccine booster available to Americans for free at pharmacies, doctor’s offices, health centers, and state and local health departments, the White House announced today. Americans can find local sites administering the vaccine booster here. Once pre-ordered doses are delivered, officials expect over 90% of Americans to have a site within five miles of where they live.

According to the Administration, the Federal Emergency Management Agency will continue to reimburse 90% of eligible costs to set up vaccination sites. The Centers for Medicare & Medicaid Services plans to share information on the new boosters with Medicare enrollees in the coming weeks, and help nursing homes plan to vaccinate residents and staff. In addition, the Department of Health and Human Services will launch a paid media campaign and work with community groups to encourage vaccination.

Among other actions, the Administration plans to purchase 100 million additional at-home COVID-19 tests for the Strategic National Stockpile; add more test-to-treat sites; and eventually transition procurement and distribution of COVID-19 vaccines, tests and treatments to the commercial market.

Related News Articles

Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
A CDC study  released Dec. 21 found low COVID-19 and flu vaccination coverage for most adults, and low RSV vaccination coverage for adults aged 60 and…
Headline
Fewer than one in four health care professionals working in acute care hospitals and nursing homes were up to date with COVID-19 vaccination during the 2022-23…
Headline
Children under age 12 should receive a 0.25 milliliter dose of the 2023-24 Moderna COVID-19 vaccine, not the full vial for that age group, the Food and Drug…
Headline
The Department of Health and Human Services Oct. 27 urged Merck and Pfizer to work with private insurers to maintain access to their COVID-19 oral antiviral…